Topic prioritisation

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Decision date

Decision date

Prioritisation routing

Prioritisation routing

Decision

Decision

Showing 1 to 10 of 376

TitlePrioritisation routingDecisionDecision date
Xeomin (botulinum neurotoxin type A) for treating lower or upper limb spasticity in people 2 to 17 years [TSID12297]None selectedNot selected
Gilteritinib + daunorubicin + cytarabine for Acute myeloid leukaemia (AML) [TSID12331]None selectedAwaiting decision
Epcoritamab + R-CHOP for Diffuse large B-cell lymphoma (DLBCL) [TSID12334]None selectedAwaiting decision
Donanemab for reducing the risk of mild cognitive impairment in preclinical Alzheimer's disease [ID6675]None selectedAwaiting decision
Pozelimab with cemdisiran for treating symptomatic generalised myasthenia gravis [TSID12287]None selectedAwaiting decision
Lanadelumab for preventing recurrent attacks of hereditary angioedema in people 2 years and over [TSID12298]None selectedNot selected
Ivacaftor–tezacaftor–elaxcaftor and ivacaftor for treating cystic fibrosis with at least 1 F508del mutation in the CFTR gene in people 1 to under 2 years [TSID12295]None selectedNot selected
Vanzacaftor–tezacaftor–deutivacaftor for treating cystic fibrosis with 1 or more responsive mutations in the CFTR gene in people 2 to 5 years [TSID12296]None selectedNot selected
Thermal Probe Ablation for abdominal wall endometriosisNone selectedAwaiting decision
Vacuum Assisted Excision for the removal of breast lesions of uncertain malignant potentialNone selectedNot selected

Results per page

  1. 10
  2. 25
  3. 50
  4. All